Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

TUCSON, AZ / ACCESS Newswire / December 8, 2025 / Umbrella Labs today announced the launch of its research-use-only MK-677 ...

New research from the University of Minnesota School of Public Health provides the first detailed look at whether funding ...

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-class immunotherapies GlycoNex, Inc.

Are you planning to pursue higher education in Australia? Check out one of the best degrees that you can study for high pay, ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation ...

The fate of the centers isn't sealed, since Congress ultimately has the power to assign funds. But until a decision is made, ...

Swiss incubator Xlife Sciences today announced that Mexico-based Grupo Landsteiner has signed a binding framework to acquire ...

A webcast of the conference call can be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ...

Explore how India's top B-schools are prioritizing storytelling to equip future leaders with essential communication skills.